Close
Nordic 9Nordic 9

SphingoTec (private company)

Germany sphingotec.com
See something wrong or missing? Let us know
Offices:Berlin
Industry:BiotechHealth servicesPharma
Business model:B2B

SphingoTec is a biotech startup in Germany developing innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 5.42M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to SphingoTec

Name Criteria
Denmark Octarine Bio
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Netherlands InnoSIGN
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Mable
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Switzerland Mybacs
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Belgium EsoBiotec
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Senisca
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France PEP-Therapy
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Sweden Oncorena
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom CardiaTec Biosciences
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Denmark Breye Therapeutics
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Top